ConductScience.org, home

Paper39690293

Interleukin-22 promotes endometrial carcinoma cell proliferation and cycle progression via ERK1/2 and p38 activation.

Liu S and 12 others. Mol Cell Biochem, 2025. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Interleukin-22 promotes endometrial carcinoma cell proliferation and cycle progression via ERK1/2 and p38 activation. Papers, record 39690293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39690293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interleukin-22 promotes endometrial carcinoma cell proliferation and cycle progression via ERK1/2 and p38 activation.
PubMed
Journal
Mol Cell Biochem
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.94, provisional
iCite
Revised in PubMed
2025-05-05
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu SShiqi
2Zhao RRuqian
3Zang YYuqin
4Huang PPengzhu
5Zhang QQiaoling
6Fan XXiangqin
7Bai JJunyi
8Zheng XXingyu
9Zhao SShuangshuang
10Kuai DDan
11Gao CChao
12Wang YYingmei
13Xue FFengxia

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InterleukinsMajor topic
Endometrial NeoplasmsMajor topic
Cell ProliferationMajor topic
MAP Kinase Signaling SystemMajor topic
p38 Mitogen-Activated Protein KinasesMajor topic
Mitogen-Activated Protein Kinase 3Major topic
Mitogen-Activated Protein Kinase 1Major topic
Neoplasm ProteinsMajor topic
Female
Humans
Interleukin-22
Animals
Mice
Cell Line, Tumor
Middle Aged
Mice, Nude

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
21JCYBJC01080Tianjin Municipal Science and Technology ProgramPubMed
TJWJ2022XK003Tianjin Municipal Health CommissionPubMed

Source PubMed

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130539314Interleukin-22 promotes tumor angiogenesis.Angiogenesis2019https://conductscience.org/library/papers/30539314PubMed
219238148Cell cycle, CDKs and cancer: a changing paradigm.Nat Rev Cancer2009https://conductscience.org/library/papers/19238148PubMed
315122762Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation.Hepatology2004https://conductscience.org/library/papers/15122762PubMed
416934487The Myc oncoprotein as a therapeutic target for human cancer.Semin Cancer Biol2006https://conductscience.org/library/papers/16934487PubMed
534300224The Assessment of IL-21 and IL-22 at the mRNA Level in Tumor Tissue and Protein Concentration in Serum and Peritoneal Fluid in Patients with Ovarian Cancer.J Clin Med2021https://conductscience.org/library/papers/34300224PubMed
627272709Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway.Sci Rep2016https://conductscience.org/library/papers/27272709PubMed
712138194Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation.Mol Cell Biol2002https://conductscience.org/library/papers/12138194PubMed
831843590Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice.Gastroenterology2020https://conductscience.org/library/papers/31843590PubMed
927473926Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways.Gynecol Oncol2016https://conductscience.org/library/papers/27473926PubMed
1036531027The roles and clinical applications of interleukins in endometrial carcinoma.Front Oncol2022https://conductscience.org/library/papers/36531027PubMed
1124378801Therapeutic opportunities of the IL-22-IL-22R1 system.Nat Rev Drug Discov2014https://conductscience.org/library/papers/24378801PubMed
1236091010IL-22 regulates endometrial regeneration by enhancing tight junctions and orchestrating extracellular matrix.Front Immunol2022https://conductscience.org/library/papers/36091010PubMed
1322922995STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma.Int J Oncol2012https://conductscience.org/library/papers/22922995PubMed
1412087100Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.J Biol Chem2002https://conductscience.org/library/papers/12087100PubMed
1510657629Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9.J Immunol2000https://conductscience.org/library/papers/10657629PubMed
1610954742Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/10954742PubMed
1735874717Immunotherapy: Reshape the Tumor Immune Microenvironment.Front Immunol2022https://conductscience.org/library/papers/35874717PubMed
1823379788IL-22 is related to development of human colon cancer by activation of STAT3.BMC Cancer2013https://conductscience.org/library/papers/23379788PubMed
1925706098Interleukin-22: immunobiology and pathology.Annu Rev Immunol2015https://conductscience.org/library/papers/25706098PubMed
2035409206Metastasis and MAPK Pathways.Int J Mol Sci2022https://conductscience.org/library/papers/35409206PubMed

See all 42 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42942215Fluoxetine Is Associated with Reduced Cell Viability and Decreased pERK1/2 Immunoreactivity in Ishikawa Endometrial Cancer Cells In Vitro: An Exploratory Study.Life (Basel)2026https://conductscience.org/library/papers/42942215PubMed
41661469Mechanism of FOXP2 in the Hepatocellular Carcinoma Progression via Ferroptosis Through RBM15B-Mediated m6A Modification.Appl Biochem Biotechnol2026https://conductscience.org/library/papers/41661469PubMed
41594384Unveiling the Genomic Landscape of Yan Goose (Anser cygnoides): Insights into Population History and Selection Signatures for Growth and Adaptation.Animals (Basel)2026https://conductscience.org/library/papers/41594384PubMed
41179292A Machine-Learning Prognostic Model for Colorectal Cancer Using a Complement-Related Risk Signature.Oncol Res2025https://conductscience.org/library/papers/41179292PubMed
40806980EphA5 Expression Predicts Better Survival Despite an Association with Proliferative Activity in Endometrial Cancer.J Clin Med2025https://conductscience.org/library/papers/40806980PubMed
40508002Endometriosis: An Immunologist's Perspective.Int J Mol Sci2025https://conductscience.org/library/papers/40508002PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39690293

GET https://conductscience.org/api/papers/v1/39690293/references?page=2